• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Lexaria Bioscience Corp. - Warrant (NQ:LEXXW)

    0.0330 -0.0058 (-14.95%)
    Streaming Delayed Price Updated: 10:47 AM EDT, Oct 15, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,062
    Open 0.0330
    Bid (Size) 0.0331 (1)
    Ask (Size) 0.0400 (8)
    Prev. Close 0.0388
    Today's Range 0.0330 - 0.0330
    52wk Range 0.0330 - 1.310
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Lexaria Bioscience Corp. Provides Strategic Update
    Via ACCESS Newswire
    Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire

    Performance

    YTD
    -95.9%
    -95.9%
    1 Month
    -52.9%
    -52.9%
    3 Month
    -80.0%
    -80.0%
    6 Month
    -91.1%
    -91.1%
    1 Year
    -96.3%
    -96.3%

    More News

    Read More
    Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire
    Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
    Via ACCESS Newswire
    Lexaria Attending BIO International Convention
    Via ACCESS Newswire
    The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
    Via ACCESS Newswire
    Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm
    Via ACCESS Newswire
    Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
    Via ACCESS Newswire
    Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
    Via ACCESS Newswire
    GLP-1 "Arms Race" Broadens to Include Dozens of Companies
    Via ACCESS Newswire
    Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
    Via ACCESS Newswire
    Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
    Via ACCESS Newswire
    Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
    Via ACCESS Newswire
    Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy
    Via ACCESS Newswire
    Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
    Via ACCESS Newswire
    Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
    Via ACCESS Newswire
    Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
    Via ACCESS Newswire
    Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
    Via ACCESS Newswire
    Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
    Via ACCESS Newswire
    Lexaria Announces $2 Million Registered Direct Offering of Common Stock
    Via ACCESS Newswire
    Lexaria Updates its Ongoing Human Study GLP-1-H24-4
    Via ACCESS Newswire
    Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology
    Via ACCESS Newswire
    Lexaria Updates its Ongoing Human Study GLP-1-H24-4
    Via ACCESS Newswire
    Lexaria's Human GLP-1 Study #5 Begins Dosing
    Via ACCESS Newswire
    Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Lexaria Bioscience Corp. - Warrant publicly traded?
    Yes, Lexaria Bioscience Corp. - Warrant is publicly traded.
    What exchange does Lexaria Bioscience Corp. - Warrant trade on?
    Lexaria Bioscience Corp. - Warrant trades on the Nasdaq Stock Market
    What is the ticker symbol for Lexaria Bioscience Corp. - Warrant?
    The ticker symbol for Lexaria Bioscience Corp. - Warrant is LEXXW on the Nasdaq Stock Market
    What is the current price of Lexaria Bioscience Corp. - Warrant?
    The current price of Lexaria Bioscience Corp. - Warrant is 0.0330
    When was Lexaria Bioscience Corp. - Warrant last traded?
    The last trade of Lexaria Bioscience Corp. - Warrant was at 10/15/25 10:47 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.